LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 82 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $4,843,000 | +7.2% | 650,000 | 0.0% | 0.77% | -11.4% |
| Q4 2016 | $4,518,000 | -99.9% | 650,000 | 0.0% | 0.87% | +1.9% |
| Q3 2016 | $5,349,500,000 | +101504.9% | 650,000 | 0.0% | 0.85% | -9.1% |
| Q2 2016 | $5,265,000 | +72.7% | 650,000 | +8.3% | 0.94% | +54.5% |
| Q1 2016 | $3,048,000 | -31.3% | 600,000 | +4.3% | 0.60% | -9.8% |
| Q4 2015 | $4,439,000 | +12.8% | 575,000 | -15.8% | 0.67% | +7.0% |
| Q3 2015 | $3,935,000 | -22.8% | 683,108 | +22.9% | 0.63% | +2.5% |
| Q2 2015 | $5,099,000 | – | 556,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 3,187,607 | $24,608,000 | 8.48% |
| ACUTA CAPITAL PARTNERS, LLC | 1,915,000 | $14,784,000 | 7.07% |
| P.A.W. CAPITAL CORP | 200,000 | $1,544,000 | 1.75% |
| Perceptive Advisors | 3,000,161 | $23,161,000 | 1.71% |
| NEXTHERA CAPITAL LP | 152,266 | $1,175,000 | 1.67% |
| Broadfin Capital, LLC | 2,105,519 | $16,255,000 | 1.00% |
| Trellus Management Company, LLC | 60,539 | $467,000 | 0.69% |
| Rhenman & Partners Asset Management AB | 575,000 | $4,439,000 | 0.67% |
| QVT Financial LP | 1,433,700 | $11,068,000 | 0.62% |
| Cormorant Asset Management, LP | 499,815 | $3,859,000 | 0.46% |